12:30 PM - 12:45 PM

First results from TITAN: A phase III double-blind, randomized study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).

Location: Le Meridian AL Khobar, Saudi Arabia

Social Share

× How can I help you?